|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||19.81 - 20.15|
|52-week range||17.25 - 25.95|
|Beta (5Y monthly)||1.10|
|PE ratio (TTM)||1.48|
|Forward dividend & yield||1.05 (5.27%)|
|Ex-dividend date||01 Aug 2022|
|1y target est||N/A|
Yahoo Finance's Brian Cheung takes a look at what's moving markets in the final hour of trading, including tech names like Apple and Microsoft.
Notable business headlines include a federal jury in Chicago convicting two former JPMorgan traders of fraud, the FCC denies SpaceX $1 billion subsidy offer, and Amazon expanding its palm scanner payment technology into Whole Foods.
(Bloomberg) -- Taibang Biologic Group, a plasma-derived biopharmaceutical product maker, has chosen banks for an initial public offering in Hong Kong, according to people familiar with the matter.Most Read from BloombergStriking Drop in Stress Hormone Predicts Long Covid in StudyThe Fed’s Damage to the Housing Market May Last YearsGarland Seeks to Unseal Trump Warrant, Says He Approved SearchChina Has Painted Itself Into a Semiconductor CornerRuto, Odinga Shy of Victory in Latest Vote Counts: Ke